Patents by Inventor Darren Sue

Darren Sue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10650404
    Abstract: Systems and methods for operating placebo-based experiments are described for online advertisements. One or more embodiments of the disclosed systems and methods utilizes an ad swapping approach to offer placebo media exposures, at no additional cost to an advertiser. One or more embodiments further provide a native experimentation platform that allows users to run tests of ad placements to measure the effectiveness of ads and view results displayed on a user interface. The disclosed systems and methods can assign viewers into a test group if shown the test ad or a control group if shown a control ad. The control ad can be provided at no cost to the advertiser for embodiments where the placebo ad belongs to an alternative advertiser. Effectiveness of third party attribution can also be evaluated. The disclosed systems and methods can define experiment parameters, including control frequency, test viewer groups, and control viewer groups.
    Type: Grant
    Filed: September 6, 2017
    Date of Patent: May 12, 2020
    Assignee: ADOBE INC.
    Inventors: Thomas Riordan, Narayan Kinhal, John Hughes, Jason Lopatecki, Darren Sue, Christopher Bell, Matthew Ellinwood
  • Publication number: 20170372352
    Abstract: Systems and methods for operating placebo-based experiments are described for online advertisements. One or more embodiments of the disclosed systems and methods utilizes an ad swapping approach to offer placebo media exposures, at no additional cost to an advertiser. One or more embodiments further provide a native experimentation platform that allows users to run tests of ad placements to measure the effectiveness of ads and view results displayed on a user interface. The disclosed systems and methods can assign viewers into a test group if shown the test ad or a control group if shown a control ad. The control ad can be provided at no cost to the advertiser for embodiments where the placebo ad belongs to an alternative advertiser. Effectiveness of third party attribution can also be evaluated. The disclosed systems and methods can define experiment parameters, including control frequency, test viewer groups, and control viewer groups.
    Type: Application
    Filed: September 6, 2017
    Publication date: December 28, 2017
    Inventors: Thomas Riordan, Narayan Kinhal, John Hughes, Jason Lopatecki, Darren Sue, Christopher Bell, Matthew Ellinwood